Acrux Revenue and Competitors

Melbourne,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Acrux's estimated annual revenue is currently $24.7M per year.(i)
  • Acrux's estimated revenue per employee is $201,000

Employee Data

  • Acrux has 123 Employees.(i)
  • Acrux grew their employee count by 21% last year.

Acrux's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFO / Company SecretaryReveal Email/Phone
3
Product Development & Technical Affairs DirectorReveal Email/Phone
4
Technical & Project DirectorReveal Email/Phone
5
Senior Project ManagerReveal Email/Phone
6
Analytical Development ManagerReveal Email/Phone
7
HR & Facilities ManagerReveal Email/Phone
8
Regulatory Affairs ManagerReveal Email/Phone
9
Project ManagerReveal Email/Phone
10
technical affairs managerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$151.8M75511%N/AN/A
#6
$63.9M31813%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$1.7M17-6%$114.3MN/A
#9
$6.8M34-6%N/AN/A
#10
$12.5M62-9%N/AN/A
Add Company

What Is Acrux?

Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising specialty and generic topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Marketed products include Axiron®, Evamist® and Lenzetto®. More recently, in addition to specialty products, Acrux has identified and initiated development of a range of generic products. Acrux is leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring more products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.

keywords:N/A

N/A

Total Funding

123

Number of Employees

$24.7M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Acrux News

2022-04-20 - Topical Drug Delivery Market Size by Region 2022-2030 ...

Tapemark, Acrux Limited Nitto Denko Corporation Skinvisible Pharmaceuticals, Inc. Mylan Pharmaceuticals Inc. Pocono Coated Products LLC

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.8M12316%N/A
#2
$14.8M12322%N/A
#3
$17.8M12316%N/A
#4
$3.5M12341%N/A
#5
$33.2M12324%N/A